Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bao-Sheng Li

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Asian Pacific Journal of Cancer Prevention : APJCP|April 10, 2015
Morphological factors and cardiac doses in whole breast radiation for left-sided breast cancerHui Guan, Yuan-Li Dong, Li-Jie Ding, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2009
Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinomaBao-sheng Li, Tao Zhou, Zhong-tang Wang, et al.
BMC Medicine|December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinomaNing Li, Tao Wu, Yong-Gui Hong, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Asian Pacific Journal of Cancer Prevention : APJCP|April 10, 2015
Morphological factors and cardiac doses in whole breast radiation for left-sided breast cancerHui Guan, Yuan-Li Dong, Li-Jie Ding, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2009
Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinomaBao-sheng Li, Tao Zhou, Zhong-tang Wang, et al.
BMC Medicine|December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinomaNing Li, Tao Wu, Yong-Gui Hong, et al.
Pageof 6